Fortitude Family Office’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.77K Sell
398
-123
-24% -$552 ﹤0.01% 2066
2026
Q2
$2.07K Buy
521
+179
+52% +$492 ﹤0.01% 1470
2026
Q1
$458 Buy
342
+35
+11% +$70 ﹤0.01% 1762
2025
Q4
$752 Sell
307
-211
-41% -$916 ﹤0.01% 1562
2025
Q3
$3.48K Sell
518
-358
-41% -$2.34K ﹤0.01% 963
2025
Q2
$5.15K Buy
876
+348
+66% +$2.27K ﹤0.01% 781
2025
Q1
$4.43K Hold
528
– – ﹤0.01% 761
2024
Q4
$3.93K Buy
+528
New +$3.53K ﹤0.01% 902

Other funds holding TMCI

Fortitude Family Office's TMCI Position: Q3 2026 in Review

Fortitude Family Office reduced its Treace Medical Concepts (TMCI) stake by 24% in Q3 2026, selling an estimated $552 and leaving 398 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #2066.

Fortitude Family Office first reported a position in TMCI in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.15K in Q2 2025. 8 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • Fortitude Family Office held 398 shares of Treace Medical Concepts worth $1.77K as of Q3 2026.
  • Fortitude Family Office sold 123 Treace Medical Concepts shares in Q3 2026, an estimated $552.
  • Treace Medical Concepts made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2066 holding.
  • Fortitude Family Office first reported a position in Treace Medical Concepts in Q4 2024 and has held it in 8 quarters since.
  • Fortitude Family Office's Treace Medical Concepts position peaked at $5.15K in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.